Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

Angiogenesis is a key process in tumor growth and progression, which is controlled by vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs). In order to better understand the prevalence and prognostic value of VEGFR1 expression in breast cancer, a tissue microarray containing >...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Med Rep
Autors principals: Lebok, Patrick, Huber, Julia, Burandt, Eike-Christian, Lebeau, Annette, Marx, Andreas Holger, Terracciano, Luigi, Heilenkötter, Uwe, Jänicke, Fritz, Müller, Volkmar, Paluchowski, Peter, Geist, Stefan, Wilke, Christian, Simon, Ronald, Sauter, Guido, Quaas, Alexander
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2016
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940099/
https://ncbi.nlm.nih.gov/pubmed/27357606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.5430
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars